CN107080242A - 一种调理人体新陈代谢的食物 - Google Patents
一种调理人体新陈代谢的食物 Download PDFInfo
- Publication number
- CN107080242A CN107080242A CN201710497911.3A CN201710497911A CN107080242A CN 107080242 A CN107080242 A CN 107080242A CN 201710497911 A CN201710497911 A CN 201710497911A CN 107080242 A CN107080242 A CN 107080242A
- Authority
- CN
- China
- Prior art keywords
- food
- nursing
- peanut
- jujube
- black
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 31
- 230000036541 health Effects 0.000 title claims abstract description 21
- 230000004060 metabolic process Effects 0.000 title claims abstract description 18
- 230000000474 nursing effect Effects 0.000 title claims abstract description 16
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 24
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 24
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 24
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 24
- 235000020232 peanut Nutrition 0.000 claims abstract description 24
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 22
- 244000068988 Glycine max Species 0.000 claims abstract description 21
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 21
- 241000371652 Curvularia clavata Species 0.000 claims abstract description 20
- 210000000582 semen Anatomy 0.000 claims abstract description 18
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 15
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 15
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 15
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 15
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 15
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 15
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 15
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 15
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 15
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 15
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 4
- 239000002994 raw material Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 19
- 210000004185 liver Anatomy 0.000 abstract description 13
- 210000003734 kidney Anatomy 0.000 abstract description 11
- 230000007774 longterm Effects 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 6
- 210000003205 muscle Anatomy 0.000 abstract description 6
- 239000011573 trace mineral Substances 0.000 abstract description 6
- 235000013619 trace mineral Nutrition 0.000 abstract description 6
- 150000001413 amino acids Chemical class 0.000 abstract description 5
- 201000004624 Dermatitis Diseases 0.000 abstract description 4
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 206010003246 arthritis Diseases 0.000 abstract description 4
- 230000003750 conditioning effect Effects 0.000 abstract description 4
- 208000029078 coronary artery disease Diseases 0.000 abstract description 4
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 201000004384 Alopecia Diseases 0.000 abstract description 3
- 206010019468 Hemiplegia Diseases 0.000 abstract description 3
- 208000008589 Obesity Diseases 0.000 abstract description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 230000036737 immune function Effects 0.000 abstract description 3
- 235000020824 obesity Nutrition 0.000 abstract description 3
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 2
- 206010008570 Chloasma Diseases 0.000 abstract description 2
- 206010025421 Macule Diseases 0.000 abstract description 2
- 208000003351 Melanosis Diseases 0.000 abstract description 2
- 206010034464 Periarthritis Diseases 0.000 abstract description 2
- 201000004681 Psoriasis Diseases 0.000 abstract description 2
- 208000025747 Rheumatic disease Diseases 0.000 abstract description 2
- 206010000496 acne Diseases 0.000 abstract description 2
- 208000010668 atopic eczema Diseases 0.000 abstract description 2
- 230000000875 corresponding effect Effects 0.000 abstract description 2
- 230000007102 metabolic function Effects 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 230000000552 rheumatic effect Effects 0.000 abstract description 2
- 201000005671 spondyloarthropathy Diseases 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 230000009246 food effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 241001092040 Crataegus Species 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 230000035764 nutrition Effects 0.000 description 8
- 240000007594 Oryza sativa Species 0.000 description 7
- 235000007164 Oryza sativa Nutrition 0.000 description 7
- 235000009566 rice Nutrition 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 235000001465 calcium Nutrition 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 206010010144 Completed suicide Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000019395 Lactation disease Diseases 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 206010042576 Suppressed lactation Diseases 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 2
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 2
- 241001107116 Castanospermum australe Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 208000004356 Hysteria Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- -1 carrotene Chemical compound 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 229960002969 oleic acid Drugs 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000022844 Bacterial Sexually Transmitted disease Diseases 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000019624 protein content Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种调理人体新陈代谢的食物,它包括黑芝麻、黑豆、黑米、花生、山楂、大枣。它通过食物所具备的功能之间的相互配合实现对人体新陈代谢功能的调理,针对不同的人群可以起到相应的功效。具有补肝肾、强筋骨、止脱发、生新发、乌发养发、增强人体免疫功能的作用,对糖尿病、高血压、冠心病、偏瘫、关节炎、肩周炎、颈椎病、腰椎间盘突出、风湿类风湿、黄褐斑、蝴蝶斑、痤疮、青春痘、皮炎、湿疹、牛皮癣、肿瘤、肥胖等都可起到防治作用。老年人长期服用可起到强身健体、增强精力的效果,学生长期服用可以增强智力和记忆力,该产品含有人体必需的多种氨基酸及微量元素,对人体的新陈代谢及调理起到了积极的帮助作用。
Description
技术领域
本发明涉及到食物疗法的配方,具体的是一种调理人体新陈代谢的食物。
背景技术
现代社会,随着生活节奏的加快,人们的生活习惯和饮食习惯也在发生着相应的变化,人们的饮食越来越趋向于快餐化,人体对于食物中营养成分的吸收也呈现出弱化的趋势,同时,生活压力的加大对于人体的消化系统也会产生一定的阻滞。
药食同源的观点是中华原创医学之中对人类最有价值的贡献之一,五谷杂粮,有益于人体而无害于人体,因而性中,这是中华原创医学选择食品的最主要标准。通过食疗的方式一方面可以应对人体的许多疾病,在不知不觉中即可实现对人体疾病的缓解治疗,另一方面,对于身体健康的人来说,食疗的方式又可较好的增进人体的抵抗力,起到强身健体的效果。
发明内容
本发明提供了一种调理人体新陈代谢的食物,它通过食物所具备的功能之间的相互配合实现对人体新陈代谢功能的调理,针对不同的人群可以起到相应的功效。
本发明实现上述目的采用以下技术方案:
一种调理人体新陈代谢的食物,它包括黑芝麻、黑豆、黑米、花生、山楂、大枣。
一种调理人体新陈代谢的食物,它所包含的原料的质量配比如下:黑芝麻20%、黑豆30%、黑米30%、花生10%、山楂5%、大枣5%。
一种调理人体新陈代谢的食物,它采用以下的工艺流程进行制备:
1)按照上述质量配比对原料进行称取;
2)分别黑芝麻、黑豆、黑米、花生进行单炒,单炒的温度控制在150度至280之间,炒熟后进行自然降温;
3)对步骤2)中的物料和山楂、大枣进行混拌,混拌后用粉碎机粉碎成70-100目的细粉,然后包装即可。
本方中:
黑芝麻:味甘,性平,无毒。入肝、肾、肺、脾经。
功效:补肝肾,润五脏,乌须发。滋养强壮,解毒生肌。主要用于肝肾不足,四肢麻木,眩晕健忘,病后体弱,老年喘咳,乳汁不足,神经衰弱,须发早白,高血压,冠心病,肠燥便秘,腰膝酸软,步履艰难,疮疡久治不愈等。
古籍记载:
《本草纲目》“胡麻-补五脏、益气力、久服轻身不老。”
《神农本草经》“补五脏,益气力,长肌肉,增脑髓。”
《抱朴子》“耐风湿、补衰老。”
《别录》“坚筋骨、明耳目、耐饥渴、延年。”
《食疗本草》“润五脏、主火灼、填骨髓、补虚气。”
《玉秋药解》“疗皮燥发枯,肉减乳少。医一切疮痪,败毒消肿。”
《日本诸家本草》“补中益气,润养五脏,补肺气,止心惊,利大小肠。”
营养成份:黑芝麻含有脂肪、蛋白质、叶酸、尼克酸、油酸、亚油酸、棕榈酸、花生酸、廿二酸、糖类、甾醇、脂麻素、芝麻林素、脂麻油酸、维生素E、卵磷脂、钙、铜等。每100克芝麻中,含蛋白质21.9克,脂肪61.7克、钙564毫克、磷368毫克、营养之丰富是其它食品所无法与之媲美的。尤其是含铁量,居多种天然食物之首(50毫克)比猪肝还多1倍,比蛋黄多6倍。维生素E的含量也位居植物食品之冠。它所富含的亚油酸、卵磷脂、脂麻素、脂麻油酸等,都是构成人体大脑的重要“建筑材料”。因此常食可改善脑功能,增强记忆力。日本医学界认为每天一匙可增强神经功能,并可治疗神经衰弱。近年来一些学者还发现黑芝麻中含有抗氧化的晒元素,具有抗癌作用。常食黑芝麻可活血养颜、滋润皮肤和头发,使人年轻健美。同时它还有降低血脂,减少血液中凝块作用,可以预防动脉粥样硬化及心脏病。
食疗作用:益气补虚、养阴润燥,用于精血不足之晕眩、耳鸣、腰膝酸软、须发早白易脱,气血不足之乏力、面色无华、阴虚口渴、消瘦及便秘、大便出血、产后缺乳等症。治疗久病咳嗽、干咳无痰、咽干、慢性咽炎、喉炎等症,治疗头晕失眠、关节屈伸不利 、慢性风湿性关节炎、中风偏瘫,治疗疮荡,通乳,治疗阳痿、腰酸腿软。治疗老年哮喘,治疗口舌生疮、荨麻疹、皮肤瘙痒症,治疗脂溢性脱发,治疗便秘。可做老、幼、病后体弱及糖尿病患者之膳食,也可健身益寿。
黑豆:味甘,性平。入肝、肾、脾经。
功效:活血利水,祛风解毒,清热消肿,调中强身,补益止汗,滋阴润肤,补肝明目。用于水肿胀满、风毒脚气、黄疸浮肿、风痹筋孪、产后风痛、痛肿疮毒、气虚自汗、体虚盗汗、血虚目暗、耳聋耳鸣、头癖等。
古籍记载:
《神农本草经》“除痛肿者汁用,止痛。”
《名医别录》“逐水胀,下淤血,散五脏结积,祛肿除痹,止腹胀。”
《食物本草》“散五脏结积,除胃热,逐水气,消肿胀,散淤血,治湿痹,炒食消谷气,止膝痛。”
《延年秘录》“服食黑豆,令人长肌肤,益颜色,填精髓,加气力,补虚能食。”
《食疗本草》“主中风脚弱,产后诸疾。”
《食经》“疗混毒水肿,除五淋,通大便,去结积。”
营养成份:据科学研究分析,黑豆含丰富的蛋白质、脂肪、维生素、微量元素和粗纤维,其中蛋白质含量达50%以上,居豆类之首,有人计算500克黑豆的蛋白质含量相当于1000克瘦猪肉,或1500克鸡蛋,或6000克牛奶,故称为“植物蛋白质之王”。肪含量高达20%,以不饱和脂肪酸居多,吸收率达95%。其脂肪组成是:棕榈酸2.4—6.8%,硬脂酸4.4—7.3%,花生油酸0.4—1.0%,油酸32—35.6%,亚油酸51.7-57.0%,亚麻酸2-10%,其中不饱和脂肪酸达86.1%以上。此外,黑豆中还含1.64%的磷脂。故黑豆和豆油常被推荐为防治心血管疾病的理想食物,具有降胆固醇防治大脑迟钝的作用。黑豆中含有维生素、蛋黄素、核黄素、黑色素等,对人体防病抗衰、美容养颜、增加精力均有补益。它还含有钙、磷、铁、锌、铜、钼、镁、硒等微量元素,都是人体营养保健不可缺少的物质。营养学家认为,黑豆除了提供人体营养,促进健康外,还可用于食疗,特别是对高血压、心脏病、血管硬化、肾脏病、糖尿病、肥胖病等都有功效。
黑米
黑米由于其营养丰富,色昧独特,产量低,古代仅供皇帝所用,古称“贡米”。近年来,农业专家通过长期培育,大面积种植已获成功,所以我们百姓才得以享用,黑米含有十多种氨基酸及维生素和矿物质,蛋白含量高出普通大米的50%,抗癌元素晒为普通大米含量的3.25倍。
功效:开胃益中,健脾暖肝,明目活血,涓涩补精,壮阳补肾,防治风湿,用于关节风痛、脾胃不和、食欲不振、肾虚腰疼、病后体弱、瘫痪不遂、青年白发等症。民间把黑米作为“月家米”专供孕、产妇补虚养身之用。常食可黑发润肤,延年益寿。对慢性病人、康复期病人及幼儿有较好的滋补作用,能明显提高人体白色素和血红蛋白的含量,有利于心血管系统的保健,有利于儿童骨髓和大脑的发育,促进产妇、病后体弱者的康复。因此是一种理想的营养价值很高的保健食品。
古籍记载
《本草纲目》“主治走马喉痹,调中,主骨节风,瘫痪不遂,常年白发。”
《崔州记》“山兰黑米有治喉功能。”
营养成份:黑米主要成份含蛋白质11.43%,脂肪3.84%,维生素B1、B2、B6、B12、C、E、D、磷、铁、锌、硒、钼等。维生素含量比上等白米高25—172%,植物脂肪高22-25%。微量元素高1-5倍,还含有十多种氨基酸,其中8种是人体必需的氨基酸,含量比上等白米高13—20%,赖氨酸含量是白米的2-2.5倍。
花生
花生被誉为长生果,认为它是最有营养的一种果品,花生含蛋白质约30%,并含有人体8种必需的氨基酸,还含有促进脑细胞发育和增强记忆力的谷氨酸和天门冬氨酸,可谓补脑佳品,花生含脂肪50%左右,其中不饱和脂肪酸占所有脂肪酸总量的80%,种不饱和脂肪酸具有降低胆固醇和使皮肤润洁细嫩的作用,它还含有维生素E、卵磷脂、脑磷脂等神经系统需要的物质,可增强脑神经功能,可延缓衰老的进程,说得上是名副其实的长生果。花生每100克还含钙140毫克,比瘦肉高出4-11倍,还含有维生素B1、胡萝卜素、铁等20多种微量元素,说它是素中之辈也不过分,确实有不少荤菜都比不上它。花生的药用,自古就受到重视,据《本草纲目拾遗》中记载:花生有“悦脾和胃,润肺化痰、滋养调气,请咽止症”等功效,有的医书上说它有止血,阻止血栓形成,保护血管壁和降低胆固醇等作用。经常食用,可防治心血管疾病;可治营养不良、咳嗽痰多、产后缺乳等症;对慢性肾炎、腹水、白带、声音嘶哑等病也有一定疗效;花生米上的那层红皮,可治疗血小板减少、具有补血作用。
山植
山楂:酸、廿、微温。归脾胃肝经。
功能与主治:消食健胃,行气散痕,用于肉食积滞、胃院胀满、泻俐腹痛、淤血经闭、产后瘀阻、心腹刺痛、高血脂症。
成份:含山楂酸、绿原酸、熊果酸、齐墩果酸、苹果酸、酒石酸、拘擞酸、咖啡酸等有机酸,槲皮素、牡荆素、金丝桃苷、表儿茶精等黄铜类化合物,以及豆甾醇、香草醛、胡萝卜素及维生素B1、B2、C、糖类、苷类、脂肪、茶酸、钙、磷、铁等。
药理作用:1、降血脂作用,2、增加冠脉流量,3、强心作用,4、降压作用,5、抗氧化作用,6、增强免疫功能,7、抗菌作用。
临床应用:1、治疗高血脂症,2、治疗高血压病,3、治疗冠心病,4、治疗肝炎,5、治疗肾孟肾炎,6、用于止痛,7、治疗黄褐斑,8、治疗急性细菌性病疾。
大枣:甘、温,归脾胃经。
功效:补益脾胃,养血安神,补肝滋肾,润肺止咳,调营卫,解药毒等。主要用于胃虚食少,脾弱便溏,营卫不和,心悸胸闷,肾虚肝燥,气血不足等。本品熟食益心而缓中,补五脏,疗肠辟,治虚损。本品与其他药配伍又能和百药,久食有益于身体,本品益气生津、补虚润燥,凡气少津亏,病见,心中烦闷、惊悸不眠以及脏躁者均可食用。
古籍记载 :
《神农本草经》主心腹邪气,安中养牌,助十二经。平胃气,通九窍,补少气、少津液、身中不足、大惊、四肢重,和百药久服轻身延年。
《食物本草会篡》久服轻身延年,补中益气,坚志强力,除烦闷,润心肺,止咳,补五脏,泊虚损,小儿秋俐,妇人脏躁,娃振腹痛,烦躁不眠。
《本草备要》补中益气,滋脾土,润心肺,调营卫,生津液,悦颜色,通九窍,助十二经,和百药。
营养成份:中国民间有“一日三枣,长生不老”之说,相传古代有一位年己半百的老姑娘,依然是亭亭玉立,“颜如处子”,其秘诀就是她平时常吃营养特别丰富的枣。自古以来,枣被列为“五果之一”,枣树为果木之首,果肉肥厚,色美味佳,含有丰富的蛋白质(3.39%)、脂肪、糖类(73%)、生物碱、黄町、氨基酸、酒石酸、苹果酸、维生素A1、B2,C、钙、磷、钾、铁、镁等营养素,尤其是糖类和维生素C含量极为丰富,每100克鲜枣中含维生素C达300-600毫克,是柑橘含量的8-17倍、香蕉含量的50-100倍、鸭梨含量的75-150倍、苹果含量的150倍,对抗癌防癌有重要作用。英国科学家曾对163个大病初愈的人做了一次实验,结果连续服枣的人身体恢复速度比吃多种维生素的人快2倍,因而将枣称之为“活维生素C丸”。此外,枣还含丰富的维生素P,维生素P能健全人的毛细血管,对高血压及心血管疾病有很好的疗效。近年来还发现枣具有CAMP(环磷酸腺昔)活性及抗变态反应、抑制中枢神经、保肝、强身、降低胆固醇、抑制癌细胞增殖等作用。
药理作用:1、抗肿瘤作用,2、抗1型变态反应的作用,3、免疫兴奋作用,4、抗实变作用,5、抗氧化作用。
临床应用:1、治疗恨屑病,2、治疗非血小板减少性紫癫,3、预防输血反应,4、降低血清谷内转氨酶。
本发明采用上述技术方案具有以下有益效果:
本产品具有补肝肾、强筋骨、止脱发、生新发、乌发养发、增强人体免疫功能的作用,对糖尿病、高血压、冠心病、偏瘫、关节炎、肩周炎、颈椎病、腰椎间盘突出、风湿类风湿、黄褐斑、蝴蝶斑、痤疮、青春痘、皮炎、湿疹、牛皮癣、肿瘤、肥胖等都可起到防治作用。老年人长期服用可起到强身健体、增强精力的效果,学生长期服用可以增强智力和记忆力,该产品含有人体必需的多种氨基酸及微量元素,对人体的新陈代谢及调理起到了积极的帮助作用。
具体实施方式
下面结合实施例对本发明作进一步说明。
一种调理人体新陈代谢的食物,它包括黑芝麻、黑豆、黑米、花生、山楂、大枣。
一种调理人体新陈代谢的食物,它所包含的原料的质量配比如下:黑芝麻20%、黑豆30%、黑米30%、花生10%、山楂5%、大枣5%。
一种调理人体新陈代谢的食物,它采用以下的工艺流程进行制备:
1)按照上述质量配比对原料进行称取;
2)分别黑芝麻、黑豆、黑米、花生进行单炒,单炒的温度控制在150度至280之间,炒熟后进行自然降温;
3)对步骤2)中的物料和山楂、大枣进行混拌,混拌后用粉碎机粉碎成70-100目的细粉,然后包装即可。
实施例1
一种调理人体新陈代谢的食物,它所包含的原料的质量配比如下:黑芝麻20g、黑豆30g、黑米30g、花生10g、山楂5g、大枣5g。
采用以下的工艺流程进行制备:
1)按照上述质量配比对原料进行称取;
2)分别黑芝麻、黑豆、黑米、花生进行单炒,单炒的温度控制在150度至280之间,炒熟后进行自然降温;
3)对步骤2)中的物料和山楂、大枣进行混拌,混拌后用粉碎机粉碎成70-100目的细粉,然后包装即可。
使用方法为每天食用1-2次,每次的用量为30g,食用方法为采用温开水将细粉冲服。
实施例2
一种调理人体新陈代谢的食物,它所包含的原料的质量配比如下:黑芝麻25g、黑豆35g、黑米35g、花生15g、山楂10g、大枣10g。
采用以下的工艺流程进行制备:
1)按照上述质量配比对原料进行称取;
2)分别黑芝麻、黑豆、黑米、花生进行单炒,单炒的温度控制在150度至280之间,炒熟后进行自然降温;
3)对步骤2)中的物料和山楂、大枣进行混拌,混拌后用粉碎机粉碎成70-100目的细粉,然后包装即可。
使用方法为每天食用1-2次,每次的用量为30g,食用方法为采用温开水将细粉冲服。
Claims (3)
1.一种调理人体新陈代谢的食物,其特征在于:它包括黑芝麻、黑豆、黑米、花生、山楂、大枣。
2.根据权利要求1所述的一种调理人体新陈代谢的食物,其特征在于:它所包含的原料的质量配比如下:黑芝麻20%、黑豆30%、黑米30%、花生10%、山楂5%、大枣5%。
3.根据权利要求2所述的一种调理人体新陈代谢的食物,其特征在于:它采用以下的工艺流程进行制备:
1)按照上述质量配比对原料进行称取;
2)分别黑芝麻、黑豆、黑米、花生进行单炒,单炒的温度控制在150度至280之间,炒熟后进行自然降温;
3)对步骤2)中的物料和山楂、大枣进行混拌,混拌后用粉碎机粉碎成70-100目的细粉,然后包装即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710497911.3A CN107080242A (zh) | 2017-06-27 | 2017-06-27 | 一种调理人体新陈代谢的食物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710497911.3A CN107080242A (zh) | 2017-06-27 | 2017-06-27 | 一种调理人体新陈代谢的食物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107080242A true CN107080242A (zh) | 2017-08-22 |
Family
ID=59607118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710497911.3A Pending CN107080242A (zh) | 2017-06-27 | 2017-06-27 | 一种调理人体新陈代谢的食物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107080242A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110292158A (zh) * | 2018-03-21 | 2019-10-01 | 李建国 | 健康调理粉 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1090731A (zh) * | 1993-02-08 | 1994-08-17 | 陈文央 | 三黑糊 |
CN102132868A (zh) * | 2011-02-16 | 2011-07-27 | 山东省农业科学院农产品研究所 | 一种速溶超微营养粉及制备方法 |
CN106261431A (zh) * | 2016-07-29 | 2017-01-04 | 安徽恋尚你食品有限公司 | 一种含有169种原料的素食全餐固体饮料及其制备方法 |
-
2017
- 2017-06-27 CN CN201710497911.3A patent/CN107080242A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1090731A (zh) * | 1993-02-08 | 1994-08-17 | 陈文央 | 三黑糊 |
CN102132868A (zh) * | 2011-02-16 | 2011-07-27 | 山东省农业科学院农产品研究所 | 一种速溶超微营养粉及制备方法 |
CN106261431A (zh) * | 2016-07-29 | 2017-01-04 | 安徽恋尚你食品有限公司 | 一种含有169种原料的素食全餐固体饮料及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110292158A (zh) * | 2018-03-21 | 2019-10-01 | 李建国 | 健康调理粉 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102715610B (zh) | 一种山药粗粮饮料及其制备方法 | |
CN107173694A (zh) | 一种营养全面平衡的全素食代餐粉配方 | |
CN102524659A (zh) | 一种具有营养保健功能的粮食配方 | |
CN102178183A (zh) | 一种五豆综合营养食品 | |
CN101366521B (zh) | 天然型功能食品 | |
CN106360286A (zh) | 一种营养组合物及其制备方法和应用 | |
CN108991078A (zh) | 一种防控富贵病的桑叶食品及其制备方法 | |
CN102919848B (zh) | 一种可以提高免疫力的油类混合物 | |
CN103610057A (zh) | 一种提神健脑的含片 | |
CN105994748A (zh) | 老青海青稞酥油茶 | |
CN103637093A (zh) | 一种安神补脑的新型燕麦片冲剂及其加工方法 | |
CN103960426B (zh) | 一种中药减肥茶 | |
CN104856183A (zh) | 一种保健固体饮料及其制备方法 | |
CN102550936A (zh) | 营养粥及其制备方法 | |
CN106954786A (zh) | 杂粮粉及其制备方法 | |
CN104366349A (zh) | 脆枣松子营养粥及制作方法 | |
CN107080242A (zh) | 一种调理人体新陈代谢的食物 | |
CN108308523A (zh) | 一种排毒养颜代餐粉 | |
CN104222877A (zh) | 黄豆花生营养粥及制作方法 | |
CN101077187A (zh) | 药膳养颜补肾壮阳餐 | |
CN107259318A (zh) | 一种营养保健食品 | |
CN106135525A (zh) | 一种袋泡核桃红茶及其制备方法 | |
CN104738387A (zh) | 一种高丽红参大豆蛋白膨化粉的制备方法 | |
CN110506936A (zh) | 一种补肾健脾抗衰养生保健食品 | |
CN103931834A (zh) | 一种保健茶 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170822 |